August 19, 2017 11:37 AM ET

Pharmaceuticals

Company Overview of Biomarck Pharmaceuticals, Ltd.

Key Executives for Biomarck Pharmaceuticals, Ltd.

NameBoard RelationshipsTitleAge
Brian Dickson M.D.2 RelationshipsChief Executive Officer66
Indu Parikh Ph.D.11 RelationshipsCo-Founder, Chairman of the Scientific Advisory Board President, Chief Scientific Officer & Director--
Kenneth Adler Ph.D.11 RelationshipsCo-Founder, Chief Scientist and Member of Scientific Advisory Board--
Thomas H. Roberg 16 RelationshipsCo-Founder and Vice Chairman of the Board--
Michael Enright 8 RelationshipsChief Financial Officer55

Biomarck Pharmaceuticals, Ltd. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Rajin Ahuja 11 RelationshipsPalladium Life Sciences, LLC--
Thomas H. Roberg 16 RelationshipsBiomarck Pharmaceuticals, Ltd.--
Indu Parikh Ph.D. 11 RelationshipsBiomarck Pharmaceuticals, Ltd.--
Kenneth Adler Ph.D. 11 RelationshipsBiomarck Pharmaceuticals, Ltd.--
Robert Schleimer Ph.D. 24 RelationshipsBiomarck Pharmaceuticals, Ltd.--
View All Board Members

Biomarck Pharmaceuticals, Ltd. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D.Indu Parikh11 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
423.3K
Bonus
421.0K
Total Short Term Compensation
600.7K
Total Value of Options
8.1M
Compensation as of Fiscal Year
Biomarck Pharmaceuticals, Ltd. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Depomed, Inc. Announces Executive Appointments
August 17, 2017 8:28 PM ET
Merz Neuroscience Appoints Kevin O'Brien as Vice President and U.S. Head of Neuroscience Business
August 17, 2017 11:45 AM ET
Acasti Pharma Announces the Election of Directors
August 17, 2017 3:52 AM ET
Bio-Path Holdings, Inc. Announces Resignation of Directors
August 16, 2017 8:06 PM ET
AIT Therapeutics, Inc. Appoints Erick J. Lucera as Director and to Serve on the Audit Committee of the Board
August 16, 2017 7:11 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Biomarck Pharmaceuticals, Ltd., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.